← Back to all trials
Not Yet Recruiting
NCT05751538
Artificial Intelligence in Computed Tomography for Quantifying Lung Changes of Bronchiectasis Patients
Conditions: Bronchiectasis
Sex: All
Enrollment: 730
Sponsor: Ruijin Hospital
Location: China
Summary
Bronchiectasis is a chronic respiratory disease characterized by permanent bronchiectasis.The incidence and prevalence of bronchiectasis have assumed continuously grows in global.
Chest computed tomography (CT) remains the imaging standard for demonstrating cystic fibrosis (CF) airway structural disease in vivo.
However, visual scoring systems as an outcome measure are time consuming, require training and lack high reproducibility.
Our objective was to validate a fully automated artificial intelligence (AI)-driven scoring system of CF lung disease severity.
Eligibility Criteria
Inclusion Criteria:Patients diagnosed with bronchiectasis (according to the Chinese consensus, patient's previous chest CT examination must show bronchiectasis)Exclusion Criteria:Patients with CT data and medical records missing
Source: ClinicalTrials.gov (NCT05751538). StuddyBuddy aggregates publicly available trial information.